Adicet Bio
Formerly resTORbio
Pharmaceuticals
Multinational United States Est. 2014
🌐 WebsiteLinkedIn
Team
2
11-50 employees
Confidence
68/100
News
6
articles
About
Adicet Bio Inc is a preclinical-stage biotechnology company engaged in the design and development of immunotherapies for cancer and other disease indications, with a focus on novel universal immune cell therapies. The company's development is based on gamma delta T cells engineered with chimeric antigen receptors or T-cell receptors. In 2016, Adicet Bio Inc acquired Israeli company Applied Immune Technologies (AIT), which develops immunotherapies. AIT, today called Adicet Bio Israel, continues its operations in Israel as Adicet's wholly owned subsidiary.
Classification
Tags
cell-therapypharmaceuticalscancerimmunology
News (6)
Dec 6, 2021 · www.globenewswire.com
Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma Delta CAR T Investigational Cell Therapy
Sep 15, 2020 · www.globenewswire.com
growth-positive
Adicet Announces Completion of Merger with resTORbio
AcquisitionPublic TradingManagement Changes
Apr 29, 2020 · www.globenewswire.com
growth-positive
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
Acquired-byInvestment
Oct 3, 2019 · en.globes.co.il
growth-positive
aMoon invests in $80m Adicet Bio financing round
Investment
Oct 2, 2019 · www.calcalistech.com
growth-positive
Allogenic Immunotherapy Company Adicet Bio Raises $80 Million
Investment
Jan 27, 2016 · en.globes.co.il
growth-positive
Adicet buys Applied Immune Technologies
AcquisitionInvestment
Details
Employees
11-50
Exact Count
12
Founded
2014
Crunchbase
adicet-bio
Locations
Sderot Chicago 1, Haifa, Israel
Israel
Links
Website
www.adicetbio.com
LinkedIn
Profile
Admin
Last Update
Jan 27, 2025
Verified by
Jenny Sotnik-Talisman
Missing
product stage, sector, business model, video or image, markets, not claimed
Team (2)
Chen Schor
President & CEO
Reut Erel-Segal
Scientific research team leader
Internal
Created by
Yamila Silbert (yamila.urwicz@gmail.com)
Created
2018-06-24T00:00:00.000Z
Last editor
Maor Perlov (maor.perlov@sncentral.org)
Status
Public on NASDAQ on Sep, 2020;
Recent activity
Maor Perlov · Manual · 2023-02-22 17:08:41.000000
Maor Perlov · Manual · 2023-02-22 17:07:54.000000
Eran Levin · Automatic · 2024-01-25 16:22:26.000000
Maor Perlov · Manual · 2023-02-22 17:10:25.000000
Maor Perlov · Manual · 2023-02-22 17:10:50.000000
Maor Perlov · Manual · 2023-01-07 16:33:38.000000
Matan Eblagon · Automatic · 2024-12-11 14:59:19.000000
Matan Eblagon · Automatic · 2025-01-27 06:03:34.000000
Matan Eblagon · Automatic · 2024-12-11 14:59:19.000000
Maor Perlov · Automatic · 2023-01-07 16:33:49.000000
Finder · Adicet Bio · 2026